BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 20497848)

  • 21. Effect of bisphosphonate treatment on bone mineral density in patients with thalassaemia major.
    Skordis N; Ioannou YS; Kyriakou A; Savva SC; Efstathiou E; Savvides I; Christou S
    Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():144-8. PubMed ID: 19337169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment with pamidronate for osteoporosis complicating long-term intestinal failure.
    Pastore S; Londero M; Barbieri F; Di Leo G; Paparazzo R; Ventura A
    J Pediatr Gastroenterol Nutr; 2012 Nov; 55(5):615-8. PubMed ID: 22614111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening for osteoporosis.
    Croswell J
    Am Fam Physician; 2011 May; 83(10):1201-2. PubMed ID: 21568255
    [No Abstract]   [Full Text] [Related]  

  • 24. Osteoporosis: differences and similarities in male and female patients.
    Lane JM; Serota AC; Raphael B
    Orthop Clin North Am; 2006 Oct; 37(4):601-9. PubMed ID: 17141018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How to prevent glucocorticoid-induced osteoporosis.
    Dore RK
    Cleve Clin J Med; 2010 Aug; 77(8):529-36. PubMed ID: 20682515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The successful development of bisphosphonates in the therapy of osteoporosis].
    Fassbender WJ; Stumpf UC; Kurth A
    Med Klin (Munich); 2006 Jun; 101 Suppl 1():6-14. PubMed ID: 16826363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osteoporosis: pathogenesis, new therapies and surgical implications.
    Labovitz JM; Revill K
    Clin Podiatr Med Surg; 2007 Apr; 24(2):311-32. PubMed ID: 17430772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High prevalence of early-onset osteopenia/osteoporosis after allogeneic stem cell transplantation and improvement after bisphosphonate therapy.
    Yao S; McCarthy PL; Dunford LM; Roy DM; Brown K; Paplham P; Syta M; Lamonica D; Smiley S; Battiwalla M; Padmanabhan S; Hahn T
    Bone Marrow Transplant; 2008 Feb; 41(4):393-8. PubMed ID: 17994116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Osteoporosis in patients with inflammatory bowel disease: risk factors, prevention, and treatment.
    Katz S
    Rev Gastroenterol Disord; 2006; 6(2):63-71. PubMed ID: 16699475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Continuous increase in erythropoietic activity despite the improvement in bone mineral density by zoledronic acid in patients with thalassemia intermedia-induced osteoporosis.
    Voskaridou E; Christoulas D; Antoniadou L; Terpos E
    Acta Haematol; 2008; 119(1):40-4. PubMed ID: 18253025
    [No Abstract]   [Full Text] [Related]  

  • 31. Drug insight: the use of bisphosphonates for the prevention and treatment of osteoporosis in men.
    Brown SA; Guise TA
    Nat Clin Pract Urol; 2007 Jun; 4(6):310-20. PubMed ID: 17551535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In whom and how to prevent glucocorticoid-induced osteoporosis.
    Adachi JD; Papaioannou A
    Best Pract Res Clin Rheumatol; 2005 Dec; 19(6):1039-64. PubMed ID: 16301196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of osteoporosis after spinal cord injury: what can be done? Point/counterpoint.
    Bauman WA; Schnitzer TJ; Chen D
    PM R; 2010 Jun; 2(6):566-72. PubMed ID: 20630444
    [No Abstract]   [Full Text] [Related]  

  • 34. [Diagnosis and treatment of glucocorticoid-induced osteoporosis in collagen vascular disease].
    Kawano S; Kumagai S
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():504-7. PubMed ID: 18161157
    [No Abstract]   [Full Text] [Related]  

  • 35. D-hormones for prevention of bone loss after organ transplant.
    Sambrook PN
    J Rheumatol Suppl; 2005 Sep; 76():41-3. PubMed ID: 16142850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bisphosphonates and glucocorticoids: effects on bone quality.
    Lems WF
    Arthritis Rheum; 2007 Nov; 56(11):3518-22. PubMed ID: 17968935
    [No Abstract]   [Full Text] [Related]  

  • 37. Use of bisphosphonates in the management of postmenopausal osteoporosis.
    Papapoulos SE
    Ann N Y Acad Sci; 2011 Feb; 1218():15-32. PubMed ID: 20946579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Secondary osteoporosis.
    Ahmed SF; Elmantaser M
    Endocr Dev; 2009; 16():170-90. PubMed ID: 19494667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Guidelines on the management and treatment of glucocorticoid-induced osteoporosis (2004) in Japan].
    Takayanagi R
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():50-5. PubMed ID: 18161081
    [No Abstract]   [Full Text] [Related]  

  • 40. An update on osteoporosis.
    Nochowitz B; Siegert S; Wasik M
    Am J Ther; 2009; 16(5):437-45. PubMed ID: 19262365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.